Drug agency Divi’s Laboratories on Saturday reported a 29.30 % rise in its consolidated web revenue to Rs 502.02 crore for the quarter ended March 31, 2021, on account of sturdy gross sales.
The corporate had posted a web revenue of Rs 388.23 crore for the corresponding interval of the earlier fiscal, Divi’s Laboratories mentioned in a regulatory submitting.
Consolidated whole revenue of the corporate stood at Rs 1,811.71 crore for the quarter into consideration. It was Rs 1,466.44 crore for a similar interval a yr in the past, it added.
For the fiscal yr ended March this yr, the corporate posted a web revenue of Rs 1,984.29 crore as in opposition to Rs 1,376.54 crore for the earlier fiscal yr, the submitting mentioned.
The corporate’s whole revenue for the monetary yr ended March 2021 stood at Rs 7,031.96 crore. It was Rs 5,584.05 crore for the yr in the past fiscal yr, it added.
The Board of Administrators of the corporate has proposed a dividend of Rs 20 per share of face worth Rs 2 every for the monetary yr 2020-21, Divi’s Laboratories mentioned.
(Solely the headline and movie of this report might have been reworked by the Enterprise Customary workers; the remainder of the content material is auto-generated from a syndicated feed.)